Antares Pharma Inc (ATRS.OQ)
ATRS.OQ on NASDAQ Stock Exchange Capital Market
2.30USD
23 Apr 2018
2.30USD
23 Apr 2018
Change (% chg)
$0.00 (+0.00%)
$0.00 (+0.00%)
Prev Close
$2.30
$2.30
Open
$2.32
$2.32
Day's High
$2.33
$2.33
Day's Low
$2.29
$2.29
Volume
84,553
84,553
Avg. Vol
303,849
303,849
52-wk High
$4.09
$4.09
52-wk Low
$1.59
$1.59
Revenue & Earnings Per Share
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars
Consensus Estimates Analysis
No consensus analysis data available.
Valuation Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| P/E Ratio (TTM) | -- | 32.19 | 32.74 | |
| P/E High - Last 5 Yrs. | -- | 40.82 | 45.72 | |
| P/E Low - Last 5 Yrs. | -- | 20.23 | 24.22 | |
| Beta | 0.28 | 0.79 | 0.88 | |
| Price to Sales (TTM) | 305.28 | 7.40 | 5.71 | |
| Price to Book (MRQ) | -- | 13.07 | 5.37 | |
| Price to Tangible Book (MRQ) | -- | 26.47 | 6.95 | |
| Price to Cash Flow (TTM) | -- | 21.76 | 23.32 | |
| % Owned Institutions | -- | 4.99 | 2.17 | |
Dividends
| Company | industry | sector | ||
|---|---|---|---|---|
| Dividend Yield | -- | 1.03 | 1.50 | |
| Dividend Yield - 5 Year Avg | -- | 1.20 | 1.51 | |
| Dividend 5 Year Growth Rate | -- | 16.81 | 5.32 | |
| Payout Ratio(TTM) | -- | 30.00 | 43.29 | |
Growth Rates
| Company | industry | sector | ||
|---|---|---|---|---|
| Sales (MRQ) vs Qtr. 1 Yr. Ago | -64.35 | 8.43 | 9.21 | |
| Sales (TTM) vs TTM 1 Yr. Ago | -42.76 | 2.03 | 5.69 | |
| Sales - 5 Yr. Growth Rate | -5.00 | 8.75 | 10.32 | |
| EPS (MRQ) vs Qtr. 1 Yr. Ago | -54.02 | 48.75 | 19.36 | |
| EPS (TTM) vs TTM 1 Yr. Ago | -28.03 | -- | -- | |
| EPS - 5 Yr. Growth Rate | -- | 19.27 | 10.76 | |
| Capital Spending - 5 Yr. Growth Rate | 36.90 | 8.67 | 15.47 | |
Financial Strength
| Company | industry | sector | |
|---|---|---|---|
| Quick Ratio (MRQ) | 0.14 | 2.39 | 2.19 |
| Current Ratio (MRQ) | 0.22 | 3.13 | 2.98 |
| LT Debt to Equity (MRQ) | -- | 30.29 | 12.18 |
| Total Debt to Equity (MRQ) | -- | 36.88 | 16.45 |
| Interest Coverage (TTM) | -149.72 | 16.02 | 32.81 |
Profitability Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| Gross Margin (TTM) | 17.36 | 58.82 | 54.44 | |
| Gross Margin - 5 Yr. Avg. | 50.95 | 58.59 | 52.20 | |
| EBITD Margin (TTM) | -153.74 | -- | -- | |
| EBITD - 5 Yr. Avg | -110.22 | 23.26 | 10.96 | |
| Operating Margin (TTM) | -244.46 | 17.75 | 4.73 | |
| Operating Margin - 5 Yr. Avg. | -131.86 | 16.02 | 6.40 | |
| Pre-Tax Margin (TTM) | -244.96 | 17.48 | 5.57 | |
| Pre-Tax Margin - 5 Yr. Avg. | -125.55 | 16.25 | 6.81 | |
| Net Profit Margin (TTM) | -244.96 | 13.43 | 1.87 | |
| Net Profit Margin - 5 Yr. Avg. | -125.55 | 11.35 | 3.09 | |
| Effective Tax Rate (TTM) | -- | 22.58 | 23.04 | |
| Effective Tax Rate - 5 Yr. Avg. | -- | 28.85 | 23.96 | |
Efficiency
| Company | industry | sector | ||
|---|---|---|---|---|
| Revenue/Employee (TTM) | 53,082 | 26,739,010 | 846,830,978 | |
| Net Income/Employee (TTM) | -130,029 | 3,194,059 | 99,616,195 | |
| Receivable Turnover (TTM) | 10.46 | 5.08 | 5.78 | |
| Inventory Turnover (TTM) | 3.58 | 3.15 | 3.35 | |
| Asset Turnover (TTM) | 0.80 | 0.77 | 0.92 | |
Management Effectiveness
| Company | industry | sector | ||
|---|---|---|---|---|
| Return on Assets (TTM) | -195.99 | 10.45 | 10.95 | |
| Return on Assets - 5 Yr. Avg. | -60.29 | 9.08 | 12.31 | |
| Return on Investment (TTM) | -- | 13.89 | 14.38 | |
| Return on Investment - 5 Yr. Avg. | -76.85 | 11.76 | 16.10 | |
| Return on Equity (TTM) | -- | 16.72 | 16.07 | |
| Return on Equity - 5 Yr. Avg. | -79.39 | 14.17 | 17.39 | |
| 1 Year | 3 Year | 5 Year | |
|---|---|---|---|
| Sales % | -42.76 | -18.76 | -5.00 |
| EPS (TTM) % | -28.09 | -- | -- |
| Dividend % | -- | -- | -- |
Note: Units in Millions of US Dollars
Performance for Antares Pharma Inc
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.
Institutional Holders
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.